EBNEO Commentary: Reassessing INSURE: Is Lung Recruitment Necessary?
作者信息
Rub David M, Foglia Elizabeth E
机构信息
Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
出版信息
Acta Paediatr. 2025 Aug;114(8):2083-2084. doi: 10.1111/apa.70100. Epub 2025 Apr 21.
Abstract
摘要
相似文献
1
EBNEO Commentary: Reassessing INSURE: Is Lung Recruitment Necessary?循证新生儿学评论：重新评估INSURE：肺部复张是否必要？
Acta Paediatr. 2025 Aug;114(8):2083-2084. doi: 10.1111/apa.70100. Epub 2025 Apr 21.
2
Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial.肺复张改善经气管插管-表面活性物质-拔管治疗早产儿呼吸窘迫综合征的疗效：一项随机对照试验。
BMC Pediatr. 2022 Jan 3;22(1):14. doi: 10.1186/s12887-021-03096-y.
3
EBNEO Commentary: Azithromycin therapy for prevention of chronic lung disease.循证护理实践指南评论：阿奇霉素治疗预防慢性肺病
Acta Paediatr. 2025 May;114(5):1080-1081. doi: 10.1111/apa.17564. Epub 2024 Dec 26.
4
EBNEO Commentary: Early Respiratory Support Strategies in Extreme Prematurity.循证新生儿学评论：极早早产儿的早期呼吸支持策略
Acta Paediatr. 2025 Sep;114(9):2410-2411. doi: 10.1111/apa.70131. Epub 2025 May 9.
5
EBNEO COMMENTARY: Stoma or Intestinal Anastomosis for Necrotizing Enterocolitis.循证护理注释：坏死性小肠结肠炎的造口术或肠吻合术
Acta Paediatr. 2025 Aug;114(8):2085-2086. doi: 10.1111/apa.70119. Epub 2025 May 7.
6
EBNEO Commentary: Is Therapeutic Hypothermia Beneficial to Infants Born Between 33 and 35 Weeks Gestation?循证护理实践指南评论：亚低温治疗对孕33至35周出生的婴儿有益吗？
Acta Paediatr. 2025 Jul;114(7):1742-1743. doi: 10.1111/apa.70098. Epub 2025 Apr 18.
7
EBNEO Commentary: Respiratory syncytial virus vaccine in pregnancy for infant protection.循证护理实践网络评论：孕期接种呼吸道合胞病毒疫苗对婴儿的保护作用
Acta Paediatr. 2023 Nov;112(11):2449-2450. doi: 10.1111/apa.16950. Epub 2023 Aug 22.
8
EBNEO Commentary: Non-Invasive HFOV Versus Nasal CPAP for Preterm Infants.循证新生儿学评论：无创高频振荡通气与经鼻持续气道正压通气用于早产儿的比较
Acta Paediatr. 2025 Jun;114(6):1495-1496. doi: 10.1111/apa.70027. Epub 2025 Feb 8.
9
EBNEO Commentary: Video Versus Direct Laryngoscopy for Urgent Intubation of Newborn Infants.循证护理实践指南评论：新生儿紧急插管时视频喉镜与直接喉镜的比较
Acta Paediatr. 2025 Jun;114(6):1493-1494. doi: 10.1111/apa.70004. Epub 2025 Feb 3.
10
EBNEO Commentary: Parent-Guided Developmental Intervention for Infants With Very Low Birth Weight.循证护理实践指南评注：针对极低出生体重儿的家长指导下的发育干预
Acta Paediatr. 2025 May;114(5):1082-1083. doi: 10.1111/apa.17608. Epub 2025 Jan 30.
本文引用的文献
1
A Survey of Minimally Invasive Surfactant Use in the United States.美国微创表面活性剂使用情况调查
Am J Perinatol. 2025 Jun;42(8):1043-1050. doi: 10.1055/a-2453-6883. Epub 2024 Nov 25.
2
Lung Recruitment Before Surfactant Administration in Extremely Preterm Neonates: 2-Year Follow-Up of a Randomized Clinical Trial.肺复张策略在极早产儿肺表面活性物质治疗前的应用：一项随机临床试验的 2 年随访结果
JAMA Netw Open. 2024 Sep 3;7(9):e2435347. doi: 10.1001/jamanetworkopen.2024.35347.
3
Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).“IN-REC-SUR-E”与 LISA 在呼吸窘迫综合征早产儿中的比较：一项随机对照试验（IN-REC-LISA 试验）。
Trials. 2024 Jul 2;25(1):433. doi: 10.1186/s13063-024-08240-4.
4
Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.微创表面活性剂治疗与假治疗对呼吸窘迫综合征早产儿的死亡或支气管肺发育不良的影响：OPTIMIST 随机临床试验。
JAMA. 2021 Dec 28;326(24):2478-2487. doi: 10.1001/jama.2021.21892.
5
Lung recruitment before surfactant administration in extremely preterm neonates with respiratory distress syndrome (IN-REC-SUR-E): a randomised, unblinded, controlled trial.肺复张策略在前肺表面活性物质治疗呼吸窘迫综合征极低出生体重儿中的应用（IN-REC-SUR-E）：一项随机、非盲、对照试验
Lancet Respir Med. 2021 Feb;9(2):159-166. doi: 10.1016/S2213-2600(20)30179-X. Epub 2020 Jul 17.
6
Aeration strategy at birth influences the physiological response to surfactant in preterm lambs.出生时的通气策略会影响早产儿肺表面活性物质的生理反应。
Arch Dis Child Fetal Neonatal Ed. 2019 Nov;104(6):F587-F593. doi: 10.1136/archdischild-2018-316240. Epub 2019 Feb 1.
7
Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.持续充气与间歇正压通气对极早产儿支气管肺发育不良或死亡的影响：SAIL 随机临床试验。
JAMA. 2019 Mar 26;321(12):1165-1175. doi: 10.1001/jama.2019.1660.
8
Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.避免机械通气的表面活性物质治疗自主呼吸早产儿（AMV）：一项开放标签、随机、对照试验。
Lancet. 2011 Nov 5;378(9803):1627-34. doi: 10.1016/S0140-6736(11)60986-0. Epub 2011 Sep 29.
9
Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.极早早产儿在接受早期持续气道正压通气治疗时不进行强制通气使用表面活性剂：一项随机对照试验。
Pediatrics. 2009 Jan;123(1):137-42. doi: 10.1542/peds.2007-3501.
10
Prophylactic treatment of very premature infants with human surfactant.用人肺表面活性物质对极早产儿进行预防性治疗。
N Engl J Med. 1986 Sep 25;315(13):785-90. doi: 10.1056/NEJM198609253151301.
Zotero 插件